Ambirix

GSK has launched Ambirix, a new hepatits A and B vaccine with a two-dose vaccination schedule.

Ambirix confers immunity against hepatitis A and hepatitis B infection by inducing specific anti-hepatitis A and anti-hepatitis B antibodies.

The hepatitis A component of the vaccine consists of inactivated hepatitis A virus and the hepatitis B component is a surface antigen produced by recombinant DNA technology.

Ambirix is for use in non-immune patients aged 1—15 years, and unlike Twinrix (GSK’s other combined hepatitis A and B vaccine) which requires a threedose regimen, the standard primary vaccination course consists of two doses.

The first dose should be given on an elected date and the second dose given between six and 12 months later. The vaccine should be administered in a setting where completion of the two-dose course can be assured.

Protection against hepatitis B infections may not be obtained until after the second dose; Ambirix should only be used when there is a low risk of hepatitis B infection during the vaccination course.

View Ambirix drug record

Further information: GlaxoSmithKline


Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases